Acticor Biotech enrols first subject in Phase II/III stroke treatment trial
Acticor Biotech has enrolled the first US subject in the Phase II/III ACTISAVE clinical trial of glenzocimab in acute ischemic stroke patients. The first subject…
Filing Analytics
The filing analytics dashboard provides sentiment and mention analysis of company financial documents and filings such as annual, quarterly reports, and earnings transcripts in the pharma industry based on GlobalData’s Filing Analytics database. The dashboard offers insights into factors driving sentiment at a company and industry level while tracking divergence in sentiment between a company’s management vs. analysts tracking the company.
In partnership with
Filing sentiment score — pharma (last four quarters)
The filing analytics dashboard provides comprehensive analysis of pharmaceutical company filing sentiment score during last four quarters.
Top ten themes in pharma company filings (2021 vs. 2020)
The filing analytics dashboard identifies the top ten themes in pharmaceutical company filings based on GlobalData’s Filing Analytics database. The table below shows the leading ten themes in 2021 versus 2020. It also lists out five companies with the most mentions of each theme in 2021.
| Top 10 Themes | 2021 Rank | 2020 Rank | Top 5 Companies with Themes Mentions in 2021 |
|---|---|---|---|
| Intellectual Property | 4 | 5 | Zai Lab Ltd | Beam Therapeutics Inc | Immatics NV | I-Mab | SpringWorks Therapeutics Inc |
| Deal Making | 5 | 6 | Aurobindo Pharma Ltd | Grifols SA | Immatics NV | Alexion Pharmaceuticals Inc | Hutchmed China Ltd |
| Healthcare | 6 | 9 | Goodness Growth Holdings, Inc. | GW Pharmaceuticals Ltd | Jubilant Pharmova Ltd | Evotec SE | Biocon Ltd |
| Demographics | 7 | 8 | Immatics NV | SpringWorks Therapeutics Inc | Zai Lab Ltd | BioNTech SE | Curevac NV |
| Governance | 8 | 4 | PT Kimia Farma Tbk | PT Indofarma Tbk | Mediqon Group AG | Boiron SA | PT Phapros Tbk |
| Covid-19 | 9 | 7 | Fortis Healthcare Ltd | BioNTech SE | Moderna Inc | Biocon Ltd | PT Prodia DiaCRO Laboratories |
| Funding & Grants | 10 | 10 | Curevac NV | Entera Bio Ltd | BiondVax Pharmaceuticals Ltd | Livzon Pharmaceutical Group Co Ltd | Mediqon Group AG |
| Geopolitics | 1 | 2 | Zai Lab Ltd | China Medical System Holdings Ltd | BeiGene (Beijing) Co Ltd | BeiGene Ltd | PT Indofarma Tbk |
| ESG | 2 | 1 | PT Phapros Tbk | Grifols SA | PT Kimia Farma Tbk | Jubilant Pharmova Ltd | Recordati SpA |
| Innovation | 3 | 3 | Zai Lab Ltd | Evotec SE | Immatics NV | Beam Therapeutics Inc | IVERIC bio Inc |
Pharma company filing sentiment by region in 2021
The filing analytics dashboard tracks the average filing sentiment of pharmaceutical companies by HQ region in 2021 based on GlobalData’s Filing Analytics database..
Ten pharma companies with the most sentiment gain in 2021
The filing analytics dashboard lists ten pharmaceutical companies with the highest filing sentiment gain in 2021.
Pharma company filing keyword mentions (last 12 months)
The filing analytics dashboard tracks the number of keyword mentions in the pharma industry over the past 12 months.
All markets data shared in the dashboard is copyright of GlobalData PLC and is subject to the GlobalData Terms & Conditions. Content in the dashboard should not be viewed as a recommendation and should not be relied upon to make investment decisions. We make every effort to ensure our content is accurate and to correct mistakes as soon as possible. If you spot an error please email editorialenquiries@globaldata.com. Further information about our editorial standards and complaints procedure is available here. GlobalData is not responsible for the use of any content outside the scope of the GlobalData Terms & Conditions.
Latest News
View More
Atamyo doses first subject in Phase I/II muscular dystrophy therapy trial
Atamyo Therapeutics has dosed the first subject in a Phase I/II clinical trial of ATA-100 to treat FRKP-related limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9). The multicentre, two-stage…